Abstract
BackgroundMethotrexate (MTX) is the first line drug in rheumatoid arthritis (RA) patients. However MTX couldn't be treated in RA patients due to renal failure. Iguratimod is a newly-developed disease-modifying antirheumatic...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
